Handelsbanken Fonder AB - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 76 filers reported holding CASCADIAN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$311,000
-9.6%
84,0000.0%0.00%0.0%
Q3 2017$344,000
+10.3%
84,0000.0%0.00%
-50.0%
Q2 2017$312,000
-10.3%
84,0000.0%0.01%
-20.0%
Q1 2017$348,000
-3.9%
84,0000.0%0.01%
-9.1%
Q4 2016$362,00084,0000.01%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Abingworth LLP 925,000$3,783,0002.62%
EcoR1 Capital, LLC 3,000,000$12,270,0001.64%
BVF INC/IL 3,133,224$12,815,0001.63%
Sandia Holdings, LLC 927,264$3,793,0001.63%
NEA Management Company, LLC 9,064,575$37,074,0001.30%
P.A.W. CAPITAL CORP 240,000$982,0001.03%
FT Options LLC 115,206$471,0000.71%
Avoro Capital Advisors LLC 1,821,248$7,449,0000.58%
Baupost Group 8,721,079$35,669,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 681,210$2,786,0000.40%
View complete list of CASCADIAN THERAPEUTICS INC shareholders